Published on: 26-Oct-2017
LKCMedicine Nanyang Assistant Professor Luo Dahai received the prestigious EMBO Young Investigator Award, the organisation announced on 25 October 2017. He is among 28 researchers under the age of 40 from 11 countries who were recognised by Europe's foremost life sciences body for their exceptional research and scientific potential. Asst Prof Luo is one of four recipients from Asia and among three from Singapore this year, with the other two hailing from the Genome Institute of Singapore and the Institute of Molecular and Cell Biology. They join a network of 47 current and 417 past Young Investigators who represent some of the best up-and-coming group leaders in the life sciences in Europe and beyond.
EMBO Director Maria Leptin said, "It is a pleasure to welcome these outstanding scientists to the EMBO community. Between them, they carry out some of the most promising life science research that Europe has to offer, and we look forward to supporting them in their professional and scientific undertakings."
During their three-year tenure, EMBO Young Investigators receive a range of benefits, including an award of 15,000 euros and possible additional funds to support the establishment of their first independent laboratories. The scientists also receive access to core facilities at the European Molecular Biology Laboratory in Heidelberg, Germany, and funding for themselves and their group members to attend conferences.
On his award, 34-year-old Asst Prof Luo, whose research focuses on RNA viruses and host defence, said, "I am thrilled to hear the news from EMBO. It is not only recognition of the work I and my research team has done, but also the favourable environment here at NTU. It is an encouragement to continue with good science."
Long-standing EMBO Member and LKCMedicine Professor of Developmental Biology Philip Ingham FRS said in a congratulatory message to Asst Prof Luo, "I am especially pleased to hear that you have been admitted to the Young Investigator Programme – this is great news for you and great news for LKCMedicine!"
Back to listing